As PS is expressed on stressed and dying cells, AnxA5 is currently a promising vector for tumour imaging and targeted drug delivery in oncology as well as for the visualization of vulnerable plaques in patients (for review see 8,9,21). Here, ANXA5 is linked to neoplasm.